One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: Prospective follow-up of SAILS randomised trial

Thorax

Volumn 71, Issue 5, 2016, Pages 401-410

  Dinglas, Victor D ^a   Hopkins, Ramona O ^b,c,d   Wozniak, Amy W ^a,e   Hough, Catherine L ^f   Morris, Peter E ^g   Jackson, James C ^h   Mendez Tellez, Pedro A ^a   Bienvenu, O Joseph ^a   Ely, E Wesley ^h,i   Colantuoni, Elizabeth ^a,e   Needham, Dale M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROSUVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SHORT FORM 36; SURVIVAL RATE; BODY MASS; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS; EXERCISE TEST; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTOR; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; UNITED STATES; WALKING;

BODY MASS INDEX; DIABETES COMPLICATIONS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; ROSUVASTATIN CALCIUM; SEPSIS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; UNITED STATES; WALKING;

EID: 84960878017     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-208017     Document Type: Article

References (50)

1. Truwit JD, Bernard GR, Steingrub J, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014; 370: 2191-200.
2. Craig TR, Duffy MJ, Shyamsundar M, et al. A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med 2011; 183: 620-6.
3. El Gendy HA, Elsharnouby NM. Safety and vasopressor effect of rosuvastatin in septic patients. Egyptian Journal of Anaesthesia 2014; 30: 311-17.
4. Prado K, Ribeiro C, Furian T, et al. A clinical randomized trial on the use of atorvastatin in patients with sepsis or septic shock: Effects on endothelial function. Crit Care 2013; 17:S22.
5. Thomas G, Hraiech S, Loundou A, et al. Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials. Minerva Anestesiol 2015; 81: 921-30.
6. Simic I, Reiner Z. Adverse effects of statins - myths and reality. Curr Pharm Des 2015; 21: 1220-6.
7. Hough C, Ney J, Miller R, et al. Randomization to rosuvastatin is associated with neuromyopathy in patients with ARDS. Am J Respir Crit Care Med 2015; 191:A2281
8. Batt J, dos Santos CC, Cameron JI, et al. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013; 187: 238-46.
9. Tuccori M, Montagnani S, Mantarro S, et al. Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management. CNS Drugs 2014; 28: 249-72.
10. Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, et al. Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study. Am J Respir Crit Care Med 2012; 185: 517-24.
11. Davydow DS, Desai SV, Needham DM, et al. Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review. Psychosom Med 2008; 70: 512-19.
12. Parker AM, Sricharoenchai T, Raparla S, et al. Posttraumatic stress disorder in critical illness survivors: a meta-analysis. Crit Care Med 2015; 43: 1121-9.
13. Zeiher BG, Artigas A, Vincent JL, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32: 1695-702.
14. Angus DC, Laterre PF, Helterbrand J, et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 2004; 32: 2199-206.
15. Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010; 38: 1276-83.
16. Lone NI, Walsh TS. Impact of intensive care unit organ failures on mortality during the five years after a critical illness. Am J Respir Crit Care Med 2012; 186: 640-7.
17. Hermans G, Van Mechelen H, Clerckx B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2014; 190: 410-20.
18. Needham DM, Dinglas VD, Bienvenu OJ, et al. One year outcomes of initial trophic vs full enteral feeding in acute lung injury patients: prospective follow-up of the EDEN randomized trial. BMJ 2013; 346:f1532.
19. Needham DM, Dinglas VD, Morris PE, et al. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med 2013; 188: 567-76.
20. Rice TW, Wheeler AP, Thompson BT, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012; 307: 795-803.
21. Robinson KA, Dinglas VD, Sukrithan V, et al. Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participants. J Clin Epidemiol 2015; 68: 1481-7.
22. Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58: 595-602.
23. Ware JE, Jr., Kosinski M, Dewey JE. How to Score Version 2 of the SF-36 Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.
24. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
25. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005; 43: 203-20.
26. Leidy NK Psychometric properties of the functional performance inventory in patients with chronic obstructive pulmonary disease. Nurs Res 1999; 48: 20-8.
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
28. Bienvenu JB, Williams JB, Yang A, et al. Posttraumatic stress disorder in acute lung injury survivors: evaluating the Impact of Event Scale-Revised. Chest 2013; 144: 24-31.
29. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158(Pt 1): 1384-7.
30. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000; 55:M221-31.
31. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-67.
32. Mathiowetz V, Kashman N, Volland G, et al. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985; 66: 69-74.
33. Harik-Khan RI, Wise RA, Fozard JL. Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998; 158(Pt 1): 1459-64.
34. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-87.
35. Frisancho AR Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor, MI: The University of Michigan Press, 1990.
36. Harrell FE Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Secaucus, NJ: Springer-Verlag New York Inc., 2006.
37. Lachin JM Worst-rank score analysis with informatively missing observations in clinical trials. Control Clin Trials 1999; 20: 408-22.
38. Fan E, Dowdy DW, Colantuoni E, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 2014; 42: 849-59.
39. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-93.
40. Needham DM, Wozniak AW, Hough CL, et al. Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am J Respir Crit Care Med 2014; 189: 1214-24.
41. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012; 40: 502-9.
42. McAuley DF, Laffey JG, O'Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371: 1695-703.
43. Lee KT, Lai WT, Chu CS, et al. Effect of withdrawal of statin on C-reactive protein. Cardiology 2004; 102: 166-70.
44. Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105: 1446-52.
45. Varadhan R, Weiss CO, Segal JB, et al. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care 2010; 48(6 Suppl):S96-105.
46. Barnato AE, Albert SM, Angus DC, et al. Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med 2011; 183: 1037-42.
47. Davydow DS, Hough CL, Russo JE, et al. The association between intensive care unit admission and subsequent depression in patients with diabetes. Int J Geriatr Psychiatry 2012; 27: 22-30.
48. Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181: 1121-7.
49. Steiger JH, Fouladi RT. Noncentrality interval estimation and the evaluation of statistical models. In: Harlow LL, Mulaik SA, Steiger JH, eds. What if there were no significance tests? Mahwah, NJ: Erlbaum, 1997: 221-58.
50. Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego, CA: Academic Press, 1985.